Core Points - Sais Group Co., Ltd. has set the final offer price for its global issuance at HKD 131.50 per share [1] - The total number of H shares issued in this global offering is 108,619,000, with 10% allocated for public offering in Hong Kong and 90% for international placement [1] - The total funds raised from this issuance amount to approximately HKD 14.28 billion, with a net amount of about HKD 14.02 billion after deducting listing expenses [1] Public Offering - The Hong Kong public offering received strong investor interest, with a total of 202,321 valid applications, resulting in an oversubscription of 132.68 times [1] - A total of 10,861,900 shares were allocated to the public offering segment [1] International Placement - The international placement attracted 234 participants, with an oversubscription of 8.61 times, leading to the allocation of 97,757,100 shares [1] - Due to the enthusiastic response from the public offering, the company exercised its option to adjust the offering volume, issuing an additional 8,419,000 shares [2] Cornerstone Investors - The offering includes a strong lineup of cornerstone investors, with 20 institutions and individuals participating, collectively receiving 48,828,700 shares, which is 44.95% of the total global offering [2] - Notable allocations include 16,553,200 shares to the Chongqing Industry Mother Fund, representing 15.24% of the total [2] Listing Information - The H shares of Sais Group are expected to be listed on the Hong Kong Stock Exchange on November 5, 2025, under the stock code 9927, with a trading unit of 100 shares [2] - The company has applied for a waiver from the requirement to allocate shares to existing minority shareholders, allowing some existing shareholders to participate as cornerstone investors or underwriters [2]

Core Viewpoint - The company reported mixed financial results for Q3 2025, with revenue growth but a decline in net profit, and is preparing for the launch of its H-shares on the Hong Kong Stock Exchange [1][2]. Financial Performance - In Q3 2025, the company achieved revenue of 48.133 billion yuan, a year-on-year increase of 15.75%, while net profit attributable to shareholders was 2.371 billion yuan, down 1.74% [1]. - For the first three quarters of 2025, the company reported total revenue of 110.534 billion yuan, up 3.67%, and net profit attributable to shareholders of 5.312 billion yuan, an increase of 31.56% [1]. H-share Offering - The maximum offering price for the H-shares is set at 131.50 HKD per share, with additional fees, and a total of 100,200,000 H-shares will be offered globally [2][3]. - The company anticipates raising a net amount of approximately 12.9249 billion HKD, which will be allocated for R&D, new marketing channels, overseas sales, charging network services, and general corporate purposes [3].

Group 1 - The company has announced the results of its share allocation, with a total of 9 million H-shares being globally offered [1] - The offering price per share is set at HKD 50, resulting in a net fundraising of approximately HKD 390 million [1] - The H-shares will commence trading on the Hong Kong Stock Exchange on October 28, 2025, at 9:00 AM Hong Kong time [1] Group 2 - The Hong Kong public offering received a subscription rate of 2,680.04 times, indicating strong demand [1] - The international offering was subscribed 13.58 times, reflecting significant interest from global investors [1]

香港交易及結算所有限公司、香港聯合交易所有限公司（「香港聯交所」）及香港中央結算有限公 司（「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發 佈、刊發或派發。本公告並不構成亦不屬於在美國境內或於任何其他司法管轄區購買或認購證 券的任何要約或招攬的一部分。本公告所述證券並無亦不會根據《1933年美國證券法》（經不時 修訂）（「美國證券法」）或美國任何州或其他司法管轄區的證券法登記。證券不得在美國境內提 呈發售、出售、質押或以其他方式轉讓，惟獲豁免遵守美國證券法登記規定及符合任何適用的 州證券法則另作別論，或除非符合美國證券法S規例，否則不得在美國境外提呈發售、出售、 質押或以其他方式轉讓。證券不會在美國公開發售。 本公告僅作說明用途，並不構成收購、購買或認購證券的邀請或要約。本公告並非招股章程。 有意投資者於決定是否投資所提呈發售的H股前應閱覽三一重工股份有限公司（「本公司」）刊發 的日期為2025年10 ...

Group 1 - The core point of the article is the global offering of 聚水潭, with an issue price of HKD 30.60 per share and a total fundraising amount of HKD 2.086 billion, net proceeds amounting to HKD 1.938 billion [1][2] Group 2 - The number of shares offered globally is 68,166,200, with 6,816,700 shares for the Hong Kong offering and 61,349,500 shares for the international offering [1] - The subscription levels reached 1,952.95 times for the Hong Kong offering and 22.89 times for the international offering, with no trigger for the replenishment mechanism [2] - The cornerstone investors include 13 entities, with each receiving 2,543,300 shares, accounting for 3.73% of the offered shares and 48.50% of the total shares allocated to cornerstone investors [2]

Group 1 - The company SANY Heavy Industry (06031) plans to conduct an initial public offering (IPO) from October 20 to October 23, 2025, with a global offering of 580 million H-shares [1] - Approximately 10% of the shares will be offered in Hong Kong, while 90% will be available for international investors [1] - The proposed price range for the shares is between 20.3 and 21.3 Hong Kong dollars, with a minimum lot size of 200 shares [1] Group 2 - Established in 1994, the company is a leading player in the global engineering machinery industry driven by innovation [1] - The company focuses on the research, development, manufacturing, sales, and service of a full range of engineering machinery products, including excavators, concrete machinery, cranes, pile machinery, and road machinery [1]

本公告僅作說明用途，並不構成收購、購買或認購證券的邀請或要約。本公告並非招股章程。 有意投資者於決定是否投資所提呈發售的H股前應閱覽三一重工股份有限公司（「本公司」）刊發 的日期為2025年10月20日（星期一）的招股章程（「招股章程」），以獲得下文所述有關全球發售 的詳細資料。發售股份的投資決定應以招股章程所載資料為唯一依據。本公司並無亦不會根據 《1940年美國投資公司法》（經修訂）登記。 除本公告另有界定者外，本公告所用詞彙與招股章程所界定者具有相同涵義。 就全球發售而言，中信里昂證券有限公司作為穩定價格經辦人（「穩定價格經辦人」）（或其聯屬 人士或代其行事的任何人士）可代表承銷商在香港適用法律及監管規定允許的範圍內或其他地 方作出超額分配或進行交易，以在上市日期後一段有限時間，以穩定價格經辦人、其聯屬人士 或代其行事的任何人士可能釐定的價格、金額及方式將H股市價穩定或維持在高於原本應有水 平。然而，穩定價格經辦人（或其聯屬人士或代其行事的任何人士）並無責任進行任何該等穩定 價格行動。而該等穩定價格行動一旦開始，(a)將由穩定價格經辦人（或其聯屬人士或代其行事 的任何人士）全權酌情進行並以穩定價格經辦人 ...

Core Viewpoint - The company has successfully completed its global offering, raising approximately HKD 593.3 million through the issuance of 6.9 million H-shares at a price of HKD 95.6 per share [1] Group 1: Offering Details - The global offering consisted of 6.9 million H-shares, with 20% allocated to the Hong Kong public offering and 80% to international placement [1] - The Hong Kong public offering was oversubscribed by 5,657.20 times, while the international offering was oversubscribed by 18.62 times [1] Group 2: Trading Information - The H-shares are expected to commence trading on the Hong Kong Stock Exchange on October 16, 2025, at 9:00 AM Hong Kong time [1]

Core Viewpoint - Guanghe Tong plans to conduct an IPO from October 14 to October 17, 2025, aiming to globally offer approximately 135 million H-shares, with 10% allocated for Hong Kong and 90% for international investors [1] Group 1: IPO Details - The expected trading start date for the H-shares on the Hong Kong Stock Exchange is October 22, 2025, with a proposed share price range of HKD 19.88 to HKD 21.5 [1] - The company has secured agreements with several cornerstone investors, with a total subscription amount of approximately HKD 1.253 billion [1] Group 2: Fundraising and Utilization - The anticipated net proceeds from the fundraising are approximately HKD 2.689 billion [1] - The funds will primarily be allocated as follows: 55% for research and development, 15% for manufacturing facility construction, 10% for debt repayment, 10% for strategic investments, and 10% for working capital [1] Group 3: Market Position - The company is the second-largest wireless communication module provider globally, with a projected market share of 15.4% in 2024 [1]

聯席保薦人、保薦人兼整體協調人、整體協調人、 聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 Fujian Haixi Pharmaceuticals Co., Ltd. 福建海西新藥創制股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 股份代號：2637 Z:\04. IPO\162077 Project Neptune\cover\Project Neptune IPO fullcover 重要提示 重要提示： 閣下對本招股章程任何內容如有任何疑問，應諮詢獨立專業意見。 Fujian Haixi Pharmaceuticals Co., Ltd. 福建海西新藥創制股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 全球發售 全球發售項下的發售股份數目 ： 11,500,000股H股 香港發售股份數目 ： 1,150,000股H股（可 予 重 新 分 配） 國際發售股份數目 ： 10,350,000股H股（可 予 重 新 分 配） 最高發售價 ： 每 股H股86.40港 元， 另 加1.0%經 紀 佣 金、 0.0027%證 監 會 交 易 徵 費、0.00565%香港聯 交所交易費以及0.0 ...